The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
Zain Chagla
Abstract
SOURCE CITATION: N Engl J Med. 2020;383:2603-15. 33301246.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMEDLINEPediatricsInternal medicineVirologyOutbreakPolitical scienceDiseaseLawInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 Research